CliniSys Group Creates Single Brand for UK and Europe

CliniSys GroupCliniSys Group has created a single brand for its businesses in the UK and Europe, with a refreshed logo and a new website.

The move creates a unified identity for CliniSys in the UK and MIPS on the continent and underlines the group's commitment to providing end-to-end diagnostic systems to support safe and effective healthcare systems today and to drive medical innovation in the future.

Chair and chief executive Michael Simpson said: "The CliniSys Group is the largest diagnostic laboratory IT vendor in Europe. Our combined cross-discipline expertise, spanning more than 40 years, provides our customers with solutions that span the diagnostic journey.

"We have reached this position by following our core values: customer, promises, simplicity and teamwork - a commitment to providing customers with the best possible products, services and support. From late March, we have a new look but our values remain steadfast, and we look forward to continuing to care for our customers while working with them on the innovative solutions that we will all need for the future."

In the UK, CliniSys is known for its laboratory information management system which is installed in over 50% of NHS pathology laboratories. Tests for more than 40 million patients are processed on its order communications system every year with over 70% of NHS acute trusts using ICE for GP electronic requesting.

In October 2015, CliniSys was acquired by Roper Technologies and this has enabled it to add systems from complementary suppliers, such as Sunquest Information Systems and Data Innovations. This has enabled CliniSys to offer its UK customers industry-leading, end-to-end solutions, and to think creatively about meeting the needs of pathology networks, integrated care systems, and the coming world of precision medicine.

The CliniSys name is being retained in the UK, although the logo has been refreshed. Richard Craven, CliniSys chief executive, said: "Increasingly, CliniSys and MIPS have been working more collaboratively, launching common products such as our Genomics solution and developing our Cloud architecture and strategy. We have been one company for many years, and we felt now is the right time to bring our 40 year pedigree, track record and product proposition of the CliniSys Group together in one place and under one brand."

In Europe, MIPS is best known for its general laboratory information management system or GLIMS. This is the most widely used LIMS on the continent, where it is relied on by 15,000 people operating in 17 countries and ten languages.

MIPS also has a history of innovation. It has developed GLIMS Genomics as a LIMS to meet the needs of new, high-tech genetics laboratories, and seen it successfully deployed in Poitiers University Hospital. CliniSys recently brought GLIMS Genomics to the UK, which is developing its own network of genomic laboratory hubs.

CliniSys | MIPS will be the new brand for MIPS across Europe.

Alongside its new identity, CliniSys has launched a new website with information about its products, case studies highlighting the great work being done by its customers, and blogs about the development of pathology and diagnostic laboratory IT.

The website is at: www.clinisysgroup.com. There are no changes to the group's contracts, support services, product roadmap or release schedule.

About CliniSys Group

CliniSys Group is the largest laboratory diagnostic IT vendor in Europe, with leading country market shares and an innovative and wide-reaching suite of end-to-end diagnostic solutions.

Headquartered in England, with local offices in six European countries, it has for more than 40 years been at the forefront of diagnostics workflow, order communications and information management solutions supporting radiology, cardiology and all pathology disciplines including anatomical or cellular, molecular and genetics.

These encompass the complete workflow from order, clinical decision support, collection, processing, analysis, results and reporting, through integration into the clinical workflow. CliniSys Group has built an unrivalled reputation for the deployment of complex diagnostics networks and academic centres - and is the only vendor repeatably delivering across all disciplines end to end - at scale.

Most Popular Now

Early Warning System for Intensive Care …

Life-threatening situations occur time and again in an intensive care unit. To make sure that doctors can intervene in time, a team at the German Heart Center Berlin (DHZB) has...

Virtual Reality could Help to Reduce Pai…

We all feel physical pain in different ways, but people with nerve injuries often have a dysfunctional pain suppression system, making them particularly prone to discomfort. Now researchers have uncovered that...

Philips Partners with Orbita to Develop …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Orbita Inc., an innovative provider of conversational artificial intelligence (AI) solutions for healthcare, announced a partnership agreement...

CliniSys Group Creates Single Brand for …

CliniSys Group has created a single brand for its businesses in the UK and Europe, with a refreshed logo and a new website. The move creates a unified identity for CliniSys...

East Lancashire Signs Deal for Early War…

Thousands of NHS professionals across five hospitals in East Lancashire are to benefit from early warning technology that will help them detect and swiftly respond to deteriorating patients in need...

FDA Grants Oxehealth Vital Signs De Novo…

Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product, which is incorporated into Oxevision, the...

Telemedicine Improves Access to High-Qua…

The American Academy of Sleep Medicine recently published an update on the use of telemedicine for the diagnosis and treatment of sleep disorders to reflect lessons learned from the transition...

DMEA 2021: Digital Health. 100 % Virtual…

7 - 11 June 2021, Berlin, Germany. An entire week dominated by digital healthcare! With that in mind, early in June DMEA 2021 will be kicking off with a wide range...

Philips and NHS Implement the First Regi…

Royal Philips (NYSE: PHG, AEX: PHIA), announced it has supported the NHS' Cheshire and Merseyside consortium [1] to become the first regional hub supplying the United Kingdom's National COVID-19 Chest...

Child Brain Tumours can be Classified by…

Diffusion weighted imaging and machine learning can successfully classify the diagnosis and characteristics of common types of paediatric brain tumours a UK-based multi-centre study, including WMG at the University of...

AI could Crack the Language of Cancer an…

Powerful algorithms used by Netflix, Amazon and Facebook can 'predict' the biological language of cancer and neurodegenerative diseases like Alzheimer's, scientists have found.